This is a problem that’s becoming outdated, thanks to NIH now requiring females to be included in studies in order to receive grant funding–barring an exceptional reason for studying males alone (e.g., male-specific problems). They are even requiring cell lines for in vitro studies to be derived, at least in part, from females, rather than from males alone.